Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
about
Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients?Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.Angiotensin II receptor blockers: the importance of dose in cardiovascular and renal risk reduction.The effects of age and gender on the pharmacokinetics of irbesartan.Angiotensin Receptor Blockers Decrease the Risk of Major Adverse Cardiovascular Events in Patients with End-Stage Renal Disease on Maintenance Dialysis: A Nationwide Matched-Cohort StudyAngiotensin-converting enzyme 2 in the brain: properties and future directions.Surrogate biochemical markers: precise measurement for strategic drug and biologics development.Angiotensin receptors in cardiovascular diseases.Angiotensin II receptor antagonists: the prototype losartan.The arterial wall: a new pharmacological and therapeutic target.Angiotensin receptor antagonists--a new class of antihypertensive drug.Selecting and validating biologic markers for drug development.Pharmacokinetics and pharmacodynamics of irbesartan in patients with hepatic cirrhosis.Candesartan improves maximal exercise capacity in hypertensives: results of a randomized placebo-controlled crossover trial.Comparison of monotherapy with irbesartan 150 mg or amlodipine 5 mg for treatment of mild-to-moderate hypertension.
P2860
Q34070051-1A4A0F31-2EC7-4429-A54A-407D484BF5FDQ34423315-E52F3F63-CDAF-484A-BB18-C3AC9156ABE4Q35799000-61B976D2-7281-438F-A199-CDD809B72FB3Q35802781-AA9EF695-1865-4339-BD5D-3FB90C34A8EBQ35816145-33FB492C-4A54-46D4-A3C3-A98B11BEC4D5Q37155907-4F7EC466-8206-4DB1-9288-BCEA45B6FE4FQ40472868-4040F948-AD76-4307-9F06-F85A6D773332Q40599741-22D4BC3C-89B3-4CD6-953B-AD47E41712EAQ41102136-B80A94EC-6055-4F86-B1DC-6B9BCF493271Q41135818-BC532873-3BED-43CC-9939-A13B51C61D29Q41169263-41E5314B-EDF8-42E7-AE2F-96C61B8A4417Q41475050-C500BD9F-7A0A-4356-A2B7-67493EFD96FFQ42677772-A668F672-4C9D-473C-997D-3A427FC02F40Q45926616-EF40E734-6AED-405B-862C-E3A95C525833Q46479802-22406AF2-6678-4D68-A4B8-80E37B7FCE24
P2860
Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Angiotensin II receptor blocka ...... ardiovascular pharmacotherapy.
@en
type
label
Angiotensin II receptor blocka ...... ardiovascular pharmacotherapy.
@en
prefLabel
Angiotensin II receptor blocka ...... ardiovascular pharmacotherapy.
@en
P2093
P2860
P1476
Angiotensin II receptor blocka ...... ardiovascular pharmacotherapy.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1993.TB01939.X
P577
1993-11-01T00:00:00Z